Oxford is one of 28 sites that will benefit from over £160 million awarded over five years to expand early phase clinical research for the benefit of NHS patients.
The National Institute for Health Research (NIHR) announced the funding for its Clinical Research Facilities (CRF) on Monday 28 February. The NIHR Oxford Clinical Research Facility is one of five new facilities and will be hosted by Oxford University Hospitals (OUH) NHS Foundation Trust. The Oxford Health Clinical Research Facility was also awarded funding.
CRFs support the delivery of early translational and experimental medicine research, from studies testing new treatments in patients for the very first time (first-in-human trials) through to early safety and efficacy trials (Phase II trials). They provide dedicated purpose-built facilities and expertise for the delivery of high-intensity studies funded by the NIHR, charities, the life sciences industry and other organisations.
The Oxford Experimental Medicine Clinical Research Facility (EMCRF), based at the Churchill Hospital, will act as the hub of the Oxford CRF. It provides a resource for early phase, experimental research across the University of Oxford’s Medical Sciences Division. The EMCRF is central to the clinical translational strategy of the Oxford Biomedical Research Centre (BRC), providing service to all specialities in the BRC Themes.